Adenoviral transfer of the inducible nitric oxide synthase gene blocks endothelial cell apoptosis

Surgery

Volumn 122, Issue 2, 1997, Pages 255-263

  Tzeng, Edith ^a   Kim, Young Myeong ^b   Pitt, Bruce R ^b   Lizonova, Alena ^b   Kovesdi, Imre ^b   Billiar, Timothy R ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE SYNTHASE;

ADENOVIRUS; ANIMAL CELL; APOPTOSIS; ARTERY INJURY; ARTERY INTIMA PROLIFERATION; CELL PROLIFERATION; CELL REGENERATION; CELL VIABILITY; CONFERENCE PAPER; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INDUCTION; GENE TRANSFER; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; WOUND HEALING;

EID: 0030875883     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6060(97)90016-7     Document Type: Conference Paper

References (25)

1. Schmidt HHHW, Walter U. NO at work. Cell 1994;78:919-25.
2. Nathan C, Zie Q-W. Nitric oxide synthases: roles, tolls, and controls. Cell 1994;78:915-8.
3. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990's. Nature 1992;362:801-9.
4. Gibbons GH, Dzau VJ. Molecular therapies for vascular disease. Science 1996;272:689-93.
5. Guo J, Milhoan KA, Tuan RS, Lefer AM. Beneficial effect of SPM-5185, a cysteine-containing nitric oxide donor, in rat carotid artery intimai injury. Circ Res 1994;75:77-84.
6. Marks DS, Vita JA, Folts JD, Keaney JF, Welch GN, Loscalzo J. Inhibition of neointimal proliferation in rabbits after vascular injury by a single treatment with a protein adduct of nitric oxide. J Clin Invest 1995;96:2630-8.
7. von der Leyen HE, Gibbons GH, Morishita R, Lewis NP, Zhang L, Nakajima M, et al. Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci U S A 1995;92:1137-41.
8. Tzeng E, Shears LL, Robbins PD, Pitt BR, Geller DA, Watkins SC, et al. Vascular gene transfer of the human inducible nitric oxide synthase: characterization of activity and effects on myointimal hyperplasia. Molec Med 1996;2:211-25.
9. Morris SM Jr, Billiar TR. New insights into the regulation of inducible nitric oxide synthesis. Am J Physiol 1994;266:E829-39.
10. Tzeng E, Shears LL II, Lotze MT, Billiar TR. Gene therapy. Curr Prob Surg 1996;33:961-1052.
11. Guo JP, Panday MM, Consigny PM, Lefer AM. Mechanisms of vascular preservation by a novel NO donor following rat carotid artery intimai injury. Am J Physiol 1995;269:H1122-31.
12. Sarkar R, Webb RC, Stanley JC. Nitric oxide inhibition of endothelial cell mitogenesis and proliferation. Surgery 1995;118:274-9.
13. Yang W, Ando J, Korenaga R, Toyo-oka T, Kamiya A. Exogenous nitric oxide inhibits proliferation of cultured vascular endothelial cells. Biochem Biophys Res Commun 1994;203:1160-7.
14. Genaro AM, Hortelano S, Alvarez A, Martinez C, Bosca L. Splenic B lymphocyte programmed cell death is prevented by nitric oxide release through mechanisms involved sustained Bcl-2 levels. J Clin Invest 1995;95:1884-90.
15. Kim YM, de Vera ME, Watkins SC, Billiar TR. Nitric oxide protects cultured rat hepatocytes from TNFα-induced apoptosis by inducing heat shock protein 70 expression. J Biol Chem 1997;272:1402-11.
16. Mannick JB, Asano K, Izumi K, Kieff E, Stamler JS. Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. Cell 1994;79:1137-46.
17. Geller DA, Lowenstein CJ, Shapiro RA, Nussler AK, DiSilvio M, Wang SC, et al. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci U S A 1993;90:3491-5.
18. Graham FL, Smiley J, Russel WC, Mairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 1977;36:59-72.
19. Hoyt DG, Mannix RJ, Rusnak JM, Pitt BR, Lazo JS. Collagen is a survival factor against LPS-induced apoptosis in cultured sheep pulmonary artery endothelial cells. Am J Physiol 1995;269:L171-7.
20. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 1995;376:37-43.
21. Fehsel K, Kroncke KD, Meyer KL, Huber H, Wahn V, Kolb-Bachofen V. Nitric oxide induces apoptosis in mouse thymocytes. J Immunol 1995;155:2858-65.
22. Xie K, Huang S, Dong Z, Juang SH, Gutman M, Xie QW, Nathan C, et al. Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells. J Exp Med 1995;181:1333-43.
23. Steller H. Mechanisms and genes of cellular suicide. Science 1995;267:1445-9.
24. Kondo S, Kondo Y, Yin D, Barnett GH, Kaakaji R, Peterson JW, et al. Involvement of interleukin-1β-converting enzyme in apoptosis of bFGF-deprived murine aortic endothelial cells. FASEB J 1996;10:1192-7.
25. Enari M, Talanian RV, Wong WW, Nagata S. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature 1996;380:723-6.